Skip to content
Dosage GuideResearch Reference

Calcitonin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Calcitonin. All information is for educational purposes only.

Quick Answer

Calcitonin (typically salmon calcitonin) dosage varies by indication and route. For osteoporosis, nasal spray is commonly 200 IU daily, alternating nostrils. Injectable forms range from 50-100 IU daily or every other day for Paget’s disease or hypercalcemia. Doses may be adjusted based on individual response and tolerability.

→ Calcitonin Benefits→ Calcitonin Side Effects→ Full Calcitonin Profile
Table of Contents

Standard Dosage Range

Research dosing range: 200 IU daily (nasal spray for osteoporosis); 50-100 IU daily/every other day (injectable for Paget’s/hypercalcemia)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Postmenopausal Osteoporosis

200 IU1× daily
Duration

Long-term (years)

Administered as a nasal spray, alternating nostrils daily to minimize nasal irritation. Monitor bone mineral density periodically.

Paget Disease of Bone

50-100 IUDaily or every other day
Duration

3-6 months cycles

Administered subcutaneously or intramuscularly. Treatment cycles are often followed by periods of observation. Monitor alkaline phosphatase levels.

Hypercalcemia of Malignancy

4-8 IU/kgEvery 12 hours
Duration

Short-term (days)

Administered subcutaneously or intramuscularly. Higher doses may be needed initially. Monitor serum calcium levels frequently.

Acute Vertebral Compression Fractures

100-200 IUDaily
Duration

Up to 4 weeks

Administered subcutaneously or intramuscularly. Used for analgesic effect in acute fractures. Concomitant analgesics may be needed.

Timing & Frequency

Nasal spray is generally administered at the same time each day. Injectable forms can be administered at any time of day. Consistency is important.

Cycle Guidance

For Paget’s disease, treatment is typically administered in cycles lasting 3-6 months followed by a period of observation. For osteoporosis, treatment is often continuous. No specific cycling guidance beyond clinical recommendations.

Reconstitution Reference

Quick reference for reconstituting Calcitonin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 200 IU/mL or higher concentration
BAC Water VolumeNot applicable (ready-to-use solution)
Concentration & DrawReady-to-use; consult product label
StorageRefrigerate at 2–8°C. Protect from light.
StabilityConsult product label for stability after first use (nasal spray). Injectable solutions are typically single-use or multi-dose with preservatives.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the dosage for calcitonin for osteoporosis?
The standard dosage for calcitonin nasal spray for postmenopausal osteoporosis is 200 IU daily, alternating nostrils each day.
How is calcitonin administered?
Calcitonin is available as a nasal spray (e.g., Miacalcin, Fortical) and as an injectable solution for subcutaneous or intramuscular administration.
How long can I use calcitonin?
For osteoporosis, calcitonin can be used long-term, with periodic bone mineral density monitoring. For Paget’s disease, treatment is typically in cycles of 3-6 months.

Last updated: 2026-02-19